Walgreens Boots Alliance (NASDAQ:WBA) had its price target cut by Bank of America from $53.00 to $51.00 in a research report sent to investors on Monday, June 3rd, Stock Target Advisor reports. They currently have an underperform rating on the pharmacy operator’s stock.
WBA has been the topic of a number of other research reports. Zacks Investment Research raised shares of Walgreens Boots Alliance from a sell rating to a hold rating in a research note on Friday, March 29th. TheStreet downgraded shares of Walgreens Boots Alliance from a b- rating to a c+ rating in a research note on Friday, March 29th. BidaskClub downgraded shares of Walgreens Boots Alliance from a sell rating to a strong sell rating in a research note on Saturday, April 13th. Pivotal Research reduced their target price on shares of Walgreens Boots Alliance from $70.00 to $60.00 and set a hold rating on the stock in a research note on Wednesday, April 3rd. Finally, Mizuho set a $67.00 target price on shares of Walgreens Boots Alliance and gave the company a hold rating in a research note on Thursday, March 28th. Six analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the stock. The stock has an average rating of Hold and an average price target of $64.89.
Shares of WBA traded down $0.57 during mid-day trading on Monday, reaching $52.38. The stock had a trading volume of 5,944,360 shares, compared to its average volume of 6,299,333. Walgreens Boots Alliance has a 12 month low of $49.31 and a 12 month high of $86.31. The business’s fifty day moving average price is $52.14. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.38 and a current ratio of 0.78. The firm has a market capitalization of $48.32 billion, a price-to-earnings ratio of 8.70, a price-to-earnings-growth ratio of 1.06 and a beta of 0.77.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Tuesday, April 2nd. The pharmacy operator reported $1.64 EPS for the quarter, missing the consensus estimate of $1.70 by ($0.06). Walgreens Boots Alliance had a return on equity of 22.00% and a net margin of 3.77%. The company had revenue of $34.53 billion during the quarter, compared to analysts’ expectations of $34.57 billion. During the same period last year, the firm posted $1.73 EPS. Walgreens Boots Alliance’s quarterly revenue was up 4.6% compared to the same quarter last year. As a group, equities analysts anticipate that Walgreens Boots Alliance will post 5.99 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Monday, May 20th were given a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 3.36%. The ex-dividend date of this dividend was Friday, May 17th. Walgreens Boots Alliance’s payout ratio is 29.24%.
In related news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $53.05, for a total value of $1,061,000.00. Following the completion of the transaction, the chief accounting officer now directly owns 435,811 shares of the company’s stock, valued at approximately $23,119,773.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Ornella Barra acquired 18,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was bought at an average cost of $54.56 per share, with a total value of $982,080.00. Following the completion of the transaction, the chief operating officer now directly owns 26,425 shares in the company, valued at $1,441,748. The disclosure for this purchase can be found here. Corporate insiders own 15.73% of the company’s stock.
Several institutional investors have recently made changes to their positions in the stock. Weaver Consulting Group acquired a new stake in shares of Walgreens Boots Alliance during the 1st quarter worth approximately $27,000. Horizon Investments LLC acquired a new stake in shares of Walgreens Boots Alliance during the 1st quarter worth approximately $214,000. Redwood Investment Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the 1st quarter worth approximately $2,734,000. Front Row Advisors LLC grew its stake in shares of Walgreens Boots Alliance by 307.8% during the 1st quarter. Front Row Advisors LLC now owns 1,097 shares of the pharmacy operator’s stock worth $69,000 after purchasing an additional 828 shares during the period. Finally, Nordea Investment Management AB grew its stake in shares of Walgreens Boots Alliance by 2.0% during the 1st quarter. Nordea Investment Management AB now owns 7,679,640 shares of the pharmacy operator’s stock worth $485,896,000 after purchasing an additional 148,814 shares during the period. 61.52% of the stock is owned by hedge funds and other institutional investors.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: What are catch-up contributions?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.